Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Active metabolic lithiasis: A condition that requires proper evaluation and monitoring

  • Authors:
    • Cătălin Pricop
    • Marius Ivănuță
    • Dragoş Puia
  • View Affiliations / Copyright

    Affiliations: Department of Urology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iași, Romania, Department of Urology, ‘Dr C. I. Parhon’ Hospital, 700503 Iași, Romania
    Copyright: © Pricop et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 715
    |
    Published online on: October 10, 2022
       https://doi.org/10.3892/etm.2022.11651
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Kidney stone evolution is different among patients, with some exhibiting kidney stones once in a lifetime and others experiencing multiple recurrences, with some even presenting with them at short intervals of time. The present study analyzed the risk of recurrence in order to organize a personalized prophylaxis and follow‑up for the patients at risk. Prior to the analysis, the patients completed the liquids, antecedents, medication, associated pathologies and aliments questionnaire. A total of 350 patients with kidney stones were consecutively enrolled between April 2019 and April 2022. The spectroscopic analysis of stone samples was performed with the Bruker Alpha II spectrometer, while the stone morphology was assessed using the Olympus SZ61TR stereomicroscope. Intact stones were sectioned and their cores were analyzed separately. Patients with metabolically active lithiasis had stones made of cystine (CYS), uric acid (UA), brushite or calcium oxalate dihydrate. Among patients aged 18‑30 years, two morphological factors defining the metabolically active lithiasis were identified: Randall's plaques [odds ratio (OR), 8.8] and poor stone organization (OR, 12.0). In patients aged 31‑40 years, one criterion for the diagnosis of metabolically active lithiasis was the identification of pale stone color (OR, 12.0). Among the 149 patients aged >50 years, 24.8% (n=37) had UA lithiasis. Furthermore, the association of the defining elements of the metabolic syndrome significantly increased the likelihood of the lithiasis recurrence (P=0.03; OR, 4.3). The presence of kidney stones in the family history was significantly associated with the type of stone (P=0.004). Among the 7 patients with CYS stones, 71.4% of them had family history of lithiasis. The study findings suggest that the identification of Randall plaques, a light stone color or a low degree of stone organization is associated with increased odds of lithiasis recurrence.
View Figures
View References

1 

Rule AD, Lieske JC and Pais VM Jr: Management of kidney stones in 2020. JAMA. 323:1961–1962. 2020.PubMed/NCBI View Article : Google Scholar

2 

Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O and Palsson R: Temporal trends in the incidence of kidney stone disease. Kidney Int. 83:146–152. 2013.PubMed/NCBI View Article : Google Scholar

3 

Tasian GE, Kabarriti AE, Kalmus A and Furth SL: Kidney stone recurrence among children and adolescents. J Urol. 197:246–252. 2017.PubMed/NCBI View Article : Google Scholar

4 

Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A, Croppi E, Gambaro G and Heilberg IP: Defining metabolic activity of nephrolithiasis-appropriate evaluation and follow-up of stone formers. Asian J Urol. 5:235–242. 2018.PubMed/NCBI View Article : Google Scholar

5 

Daudon M, Jungers P and Bazin D: Stone morphology: Implication for pathogenesis. AIP Conference Proceedings. 104:199–215. 2008.

6 

Pricop C, Ivănuţă M, Stan A, Anton-Păduraru DT, Radavoi GD, Jinga V, Proca TM and Puia D: Correlations between stones composition, dietary and comorbidities context of the lithiasic patient. Rom J Morphol Embryol. 61:1227–1233. 2020.PubMed/NCBI View Article : Google Scholar

7 

Daudon M. Recueil des spectres infra-rouges des calculs de l'arbre urinaire et des voies biliaires et des cristalluries. Laboratoire Cristal, 2015.

8 

Romero V, Akpinar H and Assimos DG: Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol. 12:e86–e96. 2010.PubMed/NCBI

9 

Kirkali Z, Rasooly R, Star RA and Rodgers GP: Urinary stone disease: Progress, status, and needs. Urology. 86:651–653. 2015.PubMed/NCBI View Article : Google Scholar

10 

Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P, Wolfe AJ, Suryavanshi M, Ticinesi A, Meschi T, et al: Meta-analysis of clinical microbiome studies in urolithiasis reveal age, stone composition, and study location as the predominant factors in urolithiasis-associated microbiome composition. MBio. 12(e0200721)2021.PubMed/NCBI View Article : Google Scholar

11 

Pricop C and Puia D: Urolithiasis in young patients: The cost increasing! Romanian are J Urol. 16(150)2017.

12 

Tzortzis V, Mamoulakis C, Rioja J, Gravas S, Michel MC and de la Rosette JJ: Medical expulsive therapy for distal ureteral stones. Drugs. 69:677–692. 2009.PubMed/NCBI View Article : Google Scholar

13 

Varkarakis J, Protogerou V, Albanis S, Sofras F and Deliveliotis C: Comparison of success rates and financial cost of extracorporeal shock-wave lithotripsy in situ and after manipulation for proximal ureteral stones. Urol Res. 31:286–290. 2003.PubMed/NCBI View Article : Google Scholar

14 

Ljunghall S and Hedstrand H: Epidemiology of renal stones in a middle-aged male population. Acta Med Scand. 97:439–445. 1975.PubMed/NCBI View Article : Google Scholar

15 

Galan P and Hercberg S: SU.VI.MAX et NutriNet-Santé: Les enseignements des grandes cohortes. Rev Prat. 68:37–40. 2018.PubMed/NCBI(In French).

16 

Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A and Türk C: Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 67:750–763. 2015.PubMed/NCBI View Article : Google Scholar

17 

Daudon M, Jungers P, Bazin D and Williams JC Jr: Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis. 46:459–470. 2018.PubMed/NCBI View Article : Google Scholar

18 

An hypothesis for the origin of renal calculus. N Engl J Med. 214:234–237. 1936.

19 

Low RK, Stoller ML and Schreiber CK: Metabolic and urinary risk factors associated with Randall's papillary plaques. J Endourol. 14:507–510. 2000.PubMed/NCBI View Article : Google Scholar

20 

Daudon M, Bazin D and Letavernier E: Randall's plaque as the origin of calcium oxalate kidneys tones. Urolithiasis. 43 (Suppl 1):S5–S11. 2015.PubMed/NCBI View Article : Google Scholar

21 

Matlaga BR, Lingeman JC Jr, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC and Lingeman JE: Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 175:1720–1724. 2006.PubMed/NCBI View Article : Google Scholar

22 

Bouslama S, Boutefnouchet A, Hannache B, Djemil T, Kadi A, Dahdouh A, Saka S and Daudon M: Composition of 359 kidney stones from the East region of Algeria. Prog Urol. 26:41–49. 2016.PubMed/NCBI View Article : Google Scholar : (In French).

23 

Ruggera L, Chiodini S and Gambaro G: Does Randall's plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? In: Abstracts of the 11th international symposium on urolithiasis, Nice, 2-5 September 2008. UrolRes. Vol 36. pp162-163, 2008.

24 

Letavernier E, Vandermeersch S, Traxer O, Tligui M, Baud L, Ronco P, Haymann JP and Daudon M: Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine. 94(e566)2015.PubMed/NCBI View Article : Google Scholar

25 

Curhan GC, Willett WC, Rimm EB and Stampfer MJ: Family history and risk of kidneystones. J Am Soc Nephrol. 8:1568–1573. 1997.PubMed/NCBI View Article : Google Scholar

26 

Ahmadi Asr Badr Y, Hazhir S and Hasanzadeh K: Family history and age at the onset of upper urinary tract calculi. Urol J. 4:142–146. 2007.PubMed/NCBI

27 

Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R and Matlaga BR: The association of increasing body mass index and kidney stone disease. J Urol. 183:571–575. 2010.PubMed/NCBI View Article : Google Scholar

28 

Daudon M, Lacour B and Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res. 34:193–199. 2006.PubMed/NCBI View Article : Google Scholar

29 

Taylor EN, Stampfer MJ and Curhan GC: Obesity, weight gain, and the risk of kidneystones. JAMA. 293:455–462. 2005.PubMed/NCBI View Article : Google Scholar

30 

Daudon M, Lacour B and Jungers P: High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant. 20:468–469. 2005.PubMed/NCBI View Article : Google Scholar

31 

World Health Organisation (WHO): Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight, 2021. Accessed June 23, 2022.

32 

Cirillo M and Laurenzi M: Elevated blood pressure and positive history of kidney stones: Results from a population-based study. J Hypertens. 6:S485–S486. 1988.PubMed/NCBI View Article : Google Scholar

33 

Lee TT, Elkoushy MA and Andonian S: Are stone analysis results different with repeated sampling? Can Urol Assoc J. 8:E317–E322. 2014.PubMed/NCBI View Article : Google Scholar

34 

Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, et al: Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 26:543–551. 2015.PubMed/NCBI View Article : Google Scholar

35 

Howles SA and Thakker RV: Genetics of kidney stone disease. Nat Rev Urol. 17:407–421. 2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Pricop C, Ivănuță M and Puia D: Active metabolic lithiasis: A condition that requires proper evaluation and monitoring. Exp Ther Med 24: 715, 2022.
APA
Pricop, C., Ivănuță, M., & Puia, D. (2022). Active metabolic lithiasis: A condition that requires proper evaluation and monitoring. Experimental and Therapeutic Medicine, 24, 715. https://doi.org/10.3892/etm.2022.11651
MLA
Pricop, C., Ivănuță, M., Puia, D."Active metabolic lithiasis: A condition that requires proper evaluation and monitoring". Experimental and Therapeutic Medicine 24.6 (2022): 715.
Chicago
Pricop, C., Ivănuță, M., Puia, D."Active metabolic lithiasis: A condition that requires proper evaluation and monitoring". Experimental and Therapeutic Medicine 24, no. 6 (2022): 715. https://doi.org/10.3892/etm.2022.11651
Copy and paste a formatted citation
x
Spandidos Publications style
Pricop C, Ivănuță M and Puia D: Active metabolic lithiasis: A condition that requires proper evaluation and monitoring. Exp Ther Med 24: 715, 2022.
APA
Pricop, C., Ivănuță, M., & Puia, D. (2022). Active metabolic lithiasis: A condition that requires proper evaluation and monitoring. Experimental and Therapeutic Medicine, 24, 715. https://doi.org/10.3892/etm.2022.11651
MLA
Pricop, C., Ivănuță, M., Puia, D."Active metabolic lithiasis: A condition that requires proper evaluation and monitoring". Experimental and Therapeutic Medicine 24.6 (2022): 715.
Chicago
Pricop, C., Ivănuță, M., Puia, D."Active metabolic lithiasis: A condition that requires proper evaluation and monitoring". Experimental and Therapeutic Medicine 24, no. 6 (2022): 715. https://doi.org/10.3892/etm.2022.11651
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team